Log In
BCIQ
Print this Print this
 

NTHi recombinant vaccine (GSK2838497A)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionNon-typeable Haemophilus influenzae (NTHi) recombinant vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationHaemophilus
Indication DetailsPrevent non-typeable Haemophilus influenza
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today